Canada markets closed

REGENXBIO Inc. (RGNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
29.95+0.43 (+1.46%)
At close: 4:00PM EDT
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2019-12-31
2018-12-31
2017-12-31
2016-12-31
Cash flows from operating activities
Net Income
-134,848
-94,733
99,937
-73,169
-62,967
Depreciation & amortization
7,915
7,152
3,982
2,686
544
Stock based compensation
30,370
26,854
16,641
10,605
7,031
Change in working capital
-6,271
-5,325
-7,774
897
5,229
Accounts receivable
-9,914
-8,622
-16,803
561
1,073
Accounts Payable
3,832
1,528
-218
2,621
186
Other working capital
-123,346
-119,425
91,370
-65,152
-56,707
Other non-cash items
-3,277
-2,683
-8,932
-347
-399
Net cash provided by operating activites
-111,728
-107,705
104,648
-57,992
-48,558
Cash flows from investing activities
Investments in property, plant and equipment
-11,618
-11,720
-13,278
-7,160
-8,149
Purchases of investments
-155,281
-190,735
-445,829
-68,634
-45,072
Sales/Maturities of investments
310,516
296,014
179,749
71,004
72,609
Other investing activites
-
-
-
-
-225
Net cash used for investing activites
143,617
93,559
-279,358
-4,790
19,163
Cash flows from financing activities
Common stock issued
-
0
189,716
81,994
-
Other financing activites
-
-
-619
-445
-60
Net cash used privided by (used for) financing activities
7,468
8,376
204,443
84,598
119
Net change in cash
39,357
-5,770
29,733
21,816
-29,276
Cash at beginning of period
56,195
76,614
46,881
24,840
54,116
Cash at end of period
95,552
70,844
76,614
46,656
24,840
Free Cash Flow
Operating Cash Flow
-111,728
-107,705
104,648
-57,992
-48,558
Capital Expenditure
-11,618
-11,720
-13,278
-7,160
-8,149
Free Cash Flow
-123,346
-119,425
91,370
-65,152
-56,707